Filed: 8/14/2025ACC: 0001654954-25-009644
📋 What this filing means
CAMBER CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 25 equity positions with a total reported market value of $1.07B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
25
Positions
$1.07B
Total AUM (reported)
24.20M
Total Shares
Allocation by class
COM$566.10M53.1%
TR UNIT$308.93M29.0%
SPONSORED ADR$81.55M7.7%
CL A$56.79M5.3%
SHS$43.63M4.1%
COMMON STOCK$8.23M0.8%
Portfolio Concentration
Top 3$486.43M45.7%
4–10$357.75M33.6%
11–25$221.04M20.8%
Top 3 weight
45.7%
Top 10 weight
79.2%
Voting Authority Distribution
Total shares with voting rights: 24.20M
Sole
Full voting authority
24.20M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole25
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings25
Rows:
SPDR S&P 500 ETF TR
SOLEShares500K
TypeSH
Market value$308.93M
29.00%
Sole
500K
Shared
0.00
None
0.00
ZIMMER BIOMET HOLDINGS INC
SOLEShares1M
TypeSH
Market value$91.21M
8.56%
Sole
1M
Shared
0.00
None
0.00
BAXTER INTL INC
SOLEShares2.85M
TypeSH
Market value$86.30M
8.10%
Sole
2.85M
Shared
0.00
None
0.00
HUMANA INC
SOLEShares300K
TypeSH
Market value$73.34M
6.89%
Sole
300K
Shared
0.00
None
0.00
CVS HEALTH CORP
SOLEShares1.05M
TypeSH
Market value$72.43M
6.80%
Sole
1.05M
Shared
0.00
None
0.00
GLOBUS MED INC
SOLEShares800K
TypeSH
Market value$47.22M
4.43%
Sole
800K
Shared
0.00
None
0.00
ICON PLC
SOLEShares300K
TypeSH
Market value$43.63M
4.10%
Sole
300K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares250K
TypeSH
Market value$43.15M
4.05%
Sole
250K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares500K
TypeSH
Market value$39.58M
3.72%
Sole
500K
Shared
0.00
None
0.00
GSK PLC
SOLEShares1M
TypeSH
Market value$38.40M
3.60%
Sole
1M
Shared
0.00
None
0.00
PFIZER INC
SOLEShares1.50M
TypeSH
Market value$36.36M
3.41%
Sole
1.50M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares600K
TypeSH
Market value$32.98M
3.10%
Sole
600K
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
SOLEShares100K
TypeSH
Market value$31.20M
2.93%
Sole
100K
Shared
0.00
None
0.00
VIATRIS INC
SOLEShares2.75M
TypeSH
Market value$24.56M
2.31%
Sole
2.75M
Shared
0.00
None
0.00
BROOKDALE SR LIVING INC
SOLEShares2.15M
TypeSH
Market value$14.96M
1.40%
Sole
2.15M
Shared
0.00
None
0.00
ZIMVIE INC
SOLEShares1.60M
TypeSH
Market value$14.96M
1.40%
Sole
1.60M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares850K
TypeSH
Market value$14.71M
1.38%
Sole
850K
Shared
0.00
None
0.00
MYRIAD GENETICS INC
SOLEShares2M
TypeSH
Market value$10.62M
1.00%
Sole
2M
Shared
0.00
None
0.00
EVOLENT HEALTH INC
SOLEShares850K
TypeSH
Market value$9.57M
0.90%
Sole
850K
Shared
0.00
None
0.00
CONCENTRA GROUP HOLDINGS PAR
SOLEShares400K
TypeSH
Market value$8.23M
0.77%
Sole
400K
Shared
0.00
None
0.00
INOGEN INC
SOLEShares975K
TypeSH
Market value$6.85M
0.64%
Sole
975K
Shared
0.00
None
0.00
DENALI THERAPEUTICS INC
SOLEShares400K
TypeSH
Market value$5.60M
0.53%
Sole
400K
Shared
0.00
None
0.00
THERAVANCE BIOPHARMA INC
SOLEShares450K
TypeSH
Market value$4.96M
0.47%
Sole
450K
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares125K
TypeSH
Market value$2.77M
0.26%
Sole
125K
Shared
0.00
None
0.00
ORASURE TECHNOLOGIES INC
SOLEShares900K
TypeSH
Market value$2.70M
0.25%
Sole
900K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 500K | SH | $308.93M 29.00% | 500K | 0.00 | 0.00 |
ZIMMER BIOMET HOLDINGS INCSOLE | COM | 1M | SH | $91.21M 8.56% | 1M | 0.00 | 0.00 |
BAXTER INTL INCSOLE | COM | 2.85M | SH | $86.30M 8.10% | 2.85M | 0.00 | 0.00 |
HUMANA INCSOLE | COM | 300K | SH | $73.34M 6.89% | 300K | 0.00 | 0.00 |
CVS HEALTH CORPSOLE | COM | 1.05M | SH | $72.43M 6.80% | 1.05M | 0.00 | 0.00 |
GLOBUS MED INCSOLE | CL A | 800K | SH | $47.22M 4.43% | 800K | 0.00 | 0.00 |
ICON PLCSOLE | SHS | 300K | SH | $43.63M 4.10% | 300K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 250K | SH | $43.15M 4.05% | 250K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 500K | SH | $39.58M 3.72% | 500K | 0.00 | 0.00 |
GSK PLCSOLE | SPONSORED ADR | 1M | SH | $38.40M 3.60% | 1M | 0.00 | 0.00 |
PFIZER INCSOLE | COM | 1.50M | SH | $36.36M 3.41% | 1.50M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 600K | SH | $32.98M 3.10% | 600K | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCSOLE | COM | 100K | SH | $31.20M 2.93% | 100K | 0.00 | 0.00 |
VIATRIS INCSOLE | COM | 2.75M | SH | $24.56M 2.31% | 2.75M | 0.00 | 0.00 |
BROOKDALE SR LIVING INCSOLE | COM | 2.15M | SH | $14.96M 1.40% | 2.15M | 0.00 | 0.00 |
ZIMVIE INCSOLE | COM | 1.60M | SH | $14.96M 1.40% | 1.60M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 850K | SH | $14.71M 1.38% | 850K | 0.00 | 0.00 |
MYRIAD GENETICS INCSOLE | COM | 2M | SH | $10.62M 1.00% | 2M | 0.00 | 0.00 |
EVOLENT HEALTH INCSOLE | CL A | 850K | SH | $9.57M 0.90% | 850K | 0.00 | 0.00 |
CONCENTRA GROUP HOLDINGS PARSOLE | COMMON STOCK | 400K | SH | $8.23M 0.77% | 400K | 0.00 | 0.00 |
INOGEN INCSOLE | COM | 975K | SH | $6.85M 0.64% | 975K | 0.00 | 0.00 |
DENALI THERAPEUTICS INCSOLE | COM | 400K | SH | $5.60M 0.53% | 400K | 0.00 | 0.00 |
THERAVANCE BIOPHARMA INCSOLE | COM | 450K | SH | $4.96M 0.47% | 450K | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 125K | SH | $2.77M 0.26% | 125K | 0.00 | 0.00 |
ORASURE TECHNOLOGIES INCSOLE | COM | 900K | SH | $2.70M 0.25% | 900K | 0.00 | 0.00 |